SAB Biotherapeutics Inc. (SABS)
3.48
-0.07 (-1.97%)
At close: Jan 15, 2025, 3:59 PM
3.65
4.89%
After-hours Jan 15, 2025, 04:21 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -0.9 | -1.37 | -12.24 | 12.81 | -468.57 |
| PS Ratio | 16.97 | 1.07 | 3.51 | 4.67 | 1.28K |
| PB Ratio | 0.66 | 0.83 | 5.54 | 6.61 | -1.91K |
| P/FCF Ratio | -1.5 | -3.57 | -29.72 | -94.51 | -449.21 |
| P/OCF Ratio | -1.51 | 6.83 | 56.81 | 25.76 | -478.89 |
| OCF/S Ratio | -11.22 | 0.16 | 0.06 | 0.18 | -2.68 |
| Debt / Equity Ratio | 0.10 | 0.19 | 0.17 | 0.21 | -3.31 |
| Quick Ratio | 5.45 | 1.47 | 1.96 | 3.11 | 2.01 |
| Current Ratio | 5.45 | 1.47 | 1.96 | 3.11 | 2.01 |
| Asset Turnover | 0.03 | 0.47 | 0.77 | 0.98 | 0.19 |
| Interest Coverage | -120.77 | -95.89 | -45.48 | 43.82 | -20.24 |
| Return on Equity (ROE) | -0.74 | -0.6 | -0.45 | 0.52 | 4.08 |
| Return on Assets (ROA) | -0.5 | -0.37 | -0.22 | 0.36 | -0.52 |
| Return on Capital (ROIC) | -0.52 | -0.81 | -0.24 | 0.45 | -0.65 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -67.28% | 86.23% | 97.28% | 100.00% | 100.00% |
| Net Profit Margin | -1.88K% | -78.4% | -28.66% | 36.42% | -273.62% |
| Pretax Profit Margin | -1.88K% | -78.29% | -28.16% | 36.42% | -261.09% |
| Operating Profit Margin | -1.70K% | -120.97% | -22% | 37.22% | -252.01% |
| FCF Margin | -1.13K% | -30.06% | -11.8% | -4.94% | -285.41% |
| EBITDA Margin | -1.70K% | -63.26% | -24.96% | 38.26% | -239.25% |